Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience (BREATHE-easy)
Primary Purpose
Dyspnea
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PneumoCool
Current supportive measures that are used in the hospital for standard of care
Sponsored by
About this trial
This is an interventional treatment trial for Dyspnea
Eligibility Criteria
Inclusion Criteria:
- Dyspnea (Borg Scale > 3)
- Admitted to University hospital, ROSS or James Cancer Hospital with expected length of stay > 24 hours
- Age 18 years or more
Exclusion Criteria:
- Delirium (assessed by CAMICU) or dementia or brain injury precluding ability to consent and or respond to outcome scales
- Prisoner status
- Continuous mechanical ventilation
- Patients with motor disability with inability to maneuver the device
Sites / Locations
- The Ohio State UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Device arm
Standard of Care arm
Arm Description
The patients in the device arm will get the Pneumocool device to channel medical air to their face to alleviate dyspnea
The patients in the standard of care arm can get a fan or any other supportive care that is currently available in the hospital for alleviating dyspnea
Outcomes
Primary Outcome Measures
Borg Dyspnea scale ( (0 indicating no effort of breathing, 10 indicating maximal effort of breathing)
Mean changes in the Borg Dyspnea scale (0 indicating no effort of breathing, 10 indicating maximal effort of breathing)
Secondary Outcome Measures
Visual analog scale (0 indicating no trouble breathing, 10 indicating severe shortness of breath)
Mean Change visual analog scale
Supplemental oxygen
change of supplemental oxygen
External cooling devices
Duration of external cooling devices (hours)
Bronchodilator dosage
Mean changes in Bronchodilator doses
Benzodiazepine dosage
Mean changes in Benzodiazepine doses
Opoid dosage
Mean changes in Opoid doses
Bedside provider calls for dyspnea
Mean changes in bedside provider calls for dyspnea
Need for Noninvasive positive pressure ventilation [NIPPV] or Invasive mechanical ventilation)
Note the need for Noninvasive positive pressure ventilation [NPIIV] or Invasive mechanical ventilation
Hospital length of stay
Note duration of hospitalization
ICU length of stay
Note duration of ICU stay for those patients in the ICU
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05416437
Brief Title
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
Acronym
BREATHE-easy
Official Title
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 15, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ohio State University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The BREATHE-easy is a randomized control trial assessing the efficacy of the novel PneumoCool device to alleviate subjective shortness of breath. The PneumoCool device is a disposable, bladeless, highly portable device that uses medical-grade air that confers many advantages in a hospital setting.
Detailed Description
This will be randomized control trial (RCT) for patients admitted to the Ohio State University Wexner Medical Center, ROSS and James Cancer Hospital. Patients will be screened to assess eligibility. The study team will use a 2-group (intervention vs. control) RCT design. On meeting inclusion criteria, completed informed consent will be obtained. After informed consent, subjects will be randomized to receive either the PneumoCool device or usual therapy. PneumoCool setup will be done by the study team. This study will be unblinded, since blinding is not feasible in this device study. Conventional therapy will include the patients usual care and any palliation for patients' symptoms ordered by the primary team, including bedside fan if the patient requests. Patients will be queried for their symptoms at the time of enrollment, at time 0 (start of first arm of trial) and 8 hours for the primary outcome. Patient will be followed throughout their hospital stay until discharge. Data will be collected from the electronic medical record. Patient and Provider satisfaction will be noted.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyspnea
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Control Trial
Masking
None (Open Label)
Masking Description
The is an open label study. There is no masking
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Device arm
Arm Type
Active Comparator
Arm Description
The patients in the device arm will get the Pneumocool device to channel medical air to their face to alleviate dyspnea
Arm Title
Standard of Care arm
Arm Type
Placebo Comparator
Arm Description
The patients in the standard of care arm can get a fan or any other supportive care that is currently available in the hospital for alleviating dyspnea
Intervention Type
Device
Intervention Name(s)
PneumoCool
Intervention Description
Device to channel medical air to the patient to alleviate dyspnea
Intervention Type
Other
Intervention Name(s)
Current supportive measures that are used in the hospital for standard of care
Intervention Description
a room fan, or any other currently used supportive measures can be used for patients in the control arm
Primary Outcome Measure Information:
Title
Borg Dyspnea scale ( (0 indicating no effort of breathing, 10 indicating maximal effort of breathing)
Description
Mean changes in the Borg Dyspnea scale (0 indicating no effort of breathing, 10 indicating maximal effort of breathing)
Time Frame
At 8 hours after enrollment
Secondary Outcome Measure Information:
Title
Visual analog scale (0 indicating no trouble breathing, 10 indicating severe shortness of breath)
Description
Mean Change visual analog scale
Time Frame
At 8 hours after enrollment
Title
Supplemental oxygen
Description
change of supplemental oxygen
Time Frame
At 48 hours after study enrollment
Title
External cooling devices
Description
Duration of external cooling devices (hours)
Time Frame
From enrollment to hospital discharge or 30 days whichever happens earlier
Title
Bronchodilator dosage
Description
Mean changes in Bronchodilator doses
Time Frame
At 48 hours after study enrollment
Title
Benzodiazepine dosage
Description
Mean changes in Benzodiazepine doses
Time Frame
At 48 hours after study enrollment
Title
Opoid dosage
Description
Mean changes in Opoid doses
Time Frame
At 48 hours after study enrollment
Title
Bedside provider calls for dyspnea
Description
Mean changes in bedside provider calls for dyspnea
Time Frame
At 48 hours after study enrollment
Title
Need for Noninvasive positive pressure ventilation [NIPPV] or Invasive mechanical ventilation)
Description
Note the need for Noninvasive positive pressure ventilation [NPIIV] or Invasive mechanical ventilation
Time Frame
Upto hospital discharge or death which every happens earlier upto 60 day after enrollment
Title
Hospital length of stay
Description
Note duration of hospitalization
Time Frame
Upto hospital discharge or death which every happens earlier upto 60 day after enrollment
Title
ICU length of stay
Description
Note duration of ICU stay for those patients in the ICU
Time Frame
Upto transfer from ICU or death which every happens earlier upto 60 day after enrollment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
110 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Dyspnea (Borg Scale > 3)
Admitted to University hospital, ROSS or James Cancer Hospital with expected length of stay > 24 hours
Age 18 years or more
Exclusion Criteria:
Delirium (assessed by CAMICU) or dementia or brain injury precluding ability to consent and or respond to outcome scales
Prisoner status
Continuous mechanical ventilation
Patients with motor disability with inability to maneuver the device
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
sonal pannu
Phone
6142937708
Email
sonal.pannu@osumc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Sarah Karow
Phone
6142920031
Email
sarah.karow@osumc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sonal R Pannu, MD
Organizational Affiliation
Ohio State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ohio State University
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Karow
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
We'll reach out to this number within 24 hrs